Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep796 | Pituitary: clinical | ECE2015

Changes in mid-regional pro-atrial natriuretic peptide during thirsting separate patients with diabetes insipidus from those with primary polydipsia

Urwyler Sandrine , Timper Katharina , Fenske Wiebke , Kuhn Felix , Frech Nica , Arici Birsen , Rutishauser Jonas , Kopp Peter , Allolio Bruno , Stettler Christoph , Muller Beat , Katan Mira , Christ-Crain Mirjam

Background: The water deprivation test as the accepted gold standard in the differential diagnosis of polyuria polydipsia syndrome can be associated with a decrease in extracellular fluid volume in patients with diabetes insipidus (DI). We herein evaluated mid-regional pro-atrial natriuretic peptide (MR-proANP) as marker of extracellular body volume in patients with diabetes insipidus compared to primary polydipsia (PP), at baseline and after water deprivation.<p class="ab...

ea0037ep927 | Thyroid (non-cancer) | ECE2015

Health-related quality of life is reduced in treated primary hypothyroidism and with lower fT3/fT4-ratio

van Loon Hannah C M , Wouters Hanneke J C M , Kobold Anneke Muller , Slagter Sandra N , Links Thera P , van der Klauw Melanie M , Wolffenbuttel Bruce H R

Introduction: Despite adequate treatment with LT4 monotherapy, many patients with primary hypothyroidism still report complaints, as this treatment can not exactly imitate the endogenous homeostasis. We examined whether the different domains of HR-QOL were affected by the existence of a thyroid disorder and use of LT4 substitution, and whether a lower ratio of free triiodothyronine (fT3)–free thyroxine (fT4)</sup...

ea0035p713 | Neuroendocrinology | ECE2014

Copeptin for the differential diagnosis and therapy management of hyponatremia in hospitalized patients – ‘The Co-MED-Study’

Nigro Nicole , Winzeler Bettina , Suter-Widmer Isabelle , Schuetz Philipp , Arici Birsen , Bally Martina , Blum Claudine , Nickel Christian , Bingisser Roland , Bock Andreas , Huber Andreas , Muller Beat , Christ-Crain Mirjam

Background: Hyponatremia is common in hospitalized patients and its differential diagnosis and management challenging. An important mechanism is suppressed or adequately or inadequately secreted plasma arginine vasopressin (AVP). Therefore, plasma vasopressin levels may help in the differential diagnosis and in therapy management. Copeptin is secreted in an equimolar ratio to AVP and is more reliable to measure.Methods: In this prospective observational ...

ea0035p714 | Neuroendocrinology | ECE2014

Clinical symptoms and characteristics of hospitalized patients with severe hyponatremia

Nigro Nicole , Winzeler Bettina , Suter-Widmer Isabelle , Schuetz Philipp , Arici Birsen , Bally Martina , Blum Claudine , Nickel Christian , Bingisser Roland , Andreas Bock , Andreas Huber , Muller Beat , Christ-Crain Mirjam

Background: Hyponatremia is the most common electrolyte disturbance in hospitalized patients and associated with a substantial morbidity and mortality. Symptoms of severe hyponatremia vary among patients between nonspecific symptoms such as nausea or malaise or acute life threatening brain oedema. Prospective studies to assess symptoms and mortality in patients with severe hyponatremia are lacking.Methods: In this prospective multicentre observational st...

ea0070yi9 | Young Investigators | ECE2020

Comparison between the efficacy of the Anti-BAFF monoclonal antibody belimumab vs methylprednisolone in active moderate-severe graves’ orbitopathy: an interim analysis

lazzaroni Elisa , Covelli Danila , Currò Nicola , Campi Irene , Vannucchi Guia , Dazzi Davide , Muller Ilaria , Guastella Claudio , Dolci Alessia , Arosio Maura , Salvi Mario

Background: BAFF is a Serum B cell stimulating factor shown elevated in Graves’ disease, compared to controls (Vannucchi 2012). BAFF and its receptor are expressed on lymphocytes infiltrating the thyroid in Graves’ disease as well as on thyrocytes themselves (Campi 2015).Aims: A single-blind randomized controlled trial (EudraCT 2015-002127-26) has been conducted to test the efficacy of the anti-BAFF monoclonal antibody belimumab (BMB) in acti...

ea0032p201 | Cardiovascular Endocrinology &amp; Lipid Metabolism | ECE2013

Changes of expression of regulators of calcification in different stages of atherosclerosis in vasculature and bone

Schweighofer Natascha , Aigelsreiter Ariane , Graf-Rechberger Martina , Hacker Nicole , Schweiger Martin , Trummer Olivia , Pieber Thomas , Ulbing Matthias , Muller Helmut , Obermayer-Pietsch Barbara

Calcification is physiologically present in bone but also pathophysiologically in the vasculature, favouring cardiovascular diseases. Our aim was to investigate changes in the expression of calcification regulators (CR) during vascular calcification in bone and vasculature. Gene expression levels of OPG, RANKL, OPN, MGP, BSP-II and RUNX2 were determined in bone, aorta and arteria ilica externa tissue samples of 22 transplant donors. Gene expression levels during atheroscleroti...

ea0016p133 | Clinical cases | ECE2008

Cross-sex hormonal therapy in transsexuals: a survey in Munich

Bazarra-Castro Maria Angeles , Sievers Caroline , Dimopoulou Christina , Fulda Stephany , Wetter Thomas , Muller Karin , Schneider Harald , Pickel Johanna , Stalla Gunter Karl

Introduction: Transsexualism associates biological normality with the conviction of belonging to the opposite sex and the gender reassignment request. The therapy includes psychological, hormonal and surgical treatment. Only limited clinical studies addressing cross-sex hormonal therapy and side effects exist.Methods: Here, we report the results of a drafted questionnaire evaluating etiological aspects and treatment outcome. The questionnaire was distrib...

ea0056oc8.4 | MicroRNAs as biomarkers in endocrine diseases | ECE2018

Detecting blood micro-RNAs and proteins associated with Graves’ disease and orbitopathy

Biscarini Filippo , Zhang Lei , Masetti Giulia , Covelli Danila , Colucci Giuseppe , Eckstein Anja , Kaiser U , Draman Shazli , Muller Ilaria , Lucini Luigi , Ludgate Marian , Salvi Mario

Graves’ Disease (GD) affects about 2% of the population in the UK, with female predominance. A proportion of GD patients (5–50%) develop orbitopathy (GO), which is characterized by tissue remodeling in the orbit leading to protrusion of the eye (proptosis). Blood biomarkers associated with GD or GO could be useful diagnostic or prognostic tools for researchers and clinicians. Within the framework of INDIGO IAPP-612116 (Investigation of Novel biomarkers and Definition...

ea0056p576 | Obesity | ECE2018

Prevalence and pathophysiology of early dumping in patients after primary Roux-en-Y gastric bypass during a mixed meal tolerance test

Wijma Ragnild , Emous Marloes , Totte Erik , van den Broek Merel , Wolthuis Albert , Laskewitz Anke , Muller-Kobold Anneke , Wolffenbuttel Bruce , van Beek Andre

Introduction: The endocrinologist is confronted with an increasingly large population of postbariatric patients who present with endocrine problems. One of these is early dumping, a complication that may be the result of increased entero-endocrine activity. To address the prevalence of early dumping and to gain further insight into its pathophysiology, we performed a Mixed Meal Tolerance Test (MMTT) in a random sample of patients after Roux-en-Y gastric bypass (RYGB).<p cl...

ea0073yi2 | Young Investigator Awards | ECE2021

Efficacy of the Anti-BAFF monoclonal antibody belimumab vs methylprednisolone in active moderate-severe graves’ orbitopathy: Preliminary analysis of a randomized controlled trial

Vittoria Favero , Currò Nicola , Campi Irene , Lazzaroni Elisa , Covelli Danila , Vannucchi Guia , Dazzi Davide , Muller Ilaria , Minorini Valeria , Guastella Claudio , Maura Arosio , Salvi Mario

BackgroundSerum B cell stimulating factor (BAFF) has been shown to be elevated in Graves’ disease (Vannucchi 2012). In addition, BAFF and its receptor have been shown to be expressed on lymphocytes infiltrating the thyroid in Graves’ disease and also on thyrocytes (Campi 2015).AimsWe tested in a single-blind randomized controlled trial (EudraCT 2015–002127–26) whether the administration ...